{"id":"https://openalex.org/W2005297857","doi":"https://doi.org/10.3805/eands.7.55","title":"Lamotrigine monotherapy in newly diagnosed epilepsy or recurrent epilepsy:A multi-center, open-label study","display_name":"Lamotrigine monotherapy in newly diagnosed epilepsy or recurrent epilepsy:A multi-center, open-label study","alternate_titles":[],"publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W2005297857","doi":"https://doi.org/10.3805/eands.7.55","mag":"2005297857"},"language":"en","primary_location":{"id":"doi:10.3805/eands.7.55","doi":"https://doi.org/10.3805/eands.7.55","is_oa":true,"landing_page_url":"https://doi.org/10.3805/eands.7.55","pdf_url":"https://www.jstage.jst.go.jp/article/eands/7/1/7_55/_pdf","source":{"id":"https://openalex.org/S108509855","display_name":"Epilepsy & Seizure","issn_l":"1882-5567","issn":["1882-5567"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1","poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Epilepsy &amp; Seizure","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2005297857"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.jstage.jst.go.jp/article/eands/7/1/7_55/_pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011629689","display_name":"Takamichi Yamamoto","orcid":"https://orcid.org/0000-0003-4883-1551","observed_orcids":["https://orcid.org/0000-0003-4883-1551"]},"institutions":[{"id":"https://openalex.org/I4210130594","display_name":"Seirei Hamamatsu General Hospital","ror":"https://ror.org/036pfyf12","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210130594"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takamichi Yamamoto","raw_affiliation_strings":["Seirei Hamamatsu General Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seirei Hamamatsu General Hospital","institution_ids":["https://openalex.org/I4210130594"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048161203","display_name":"Seung Bong Hong","orcid":"https://orcid.org/0000-0002-8933-5709","observed_orcids":["https://orcid.org/0000-0002-8933-5709"]},"institutions":[{"id":"https://openalex.org/I2802194831","display_name":"Samsung Medical Center","ror":"https://ror.org/05a15z872","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I2250650973","https://openalex.org/I2802194831"]},{"id":"https://openalex.org/I4405271894","display_name":"Samsung Biomedical Research Institute","ror":"https://ror.org/037pjb504","country_code":"KR","type":"facility","lineage":["https://openalex.org/I4405271894"]},{"id":"https://openalex.org/I848706","display_name":"Sungkyunkwan University","ror":"https://ror.org/04q78tk20","country_code":"KR","type":"education","lineage":["https://openalex.org/I848706"]}],"countries":["KR"],"is_corresponding":false,"raw_author_name":"Seung Bong Hong","raw_affiliation_strings":["Samsung Medical Center, Sungkyunkwan University, Samsung Biomedical Research Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Samsung Medical Center, Sungkyunkwan University, Samsung Biomedical Research Institute","institution_ids":["https://openalex.org/I2802194831","https://openalex.org/I4405271894","https://openalex.org/I848706"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Masahiro Shimizu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Masahiro Shimizu","raw_affiliation_strings":["GlaxoSmithKline"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042507670","display_name":"Katsuaki Sato","orcid":"https://orcid.org/0000-0002-1844-6620","observed_orcids":["https://orcid.org/0000-0002-1844-6620"]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Katsuaki Sato","raw_affiliation_strings":["GlaxoSmithKline"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline","institution_ids":["https://openalex.org/I188950975"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5035170485","display_name":"Yotaro Numachi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I188950975","display_name":"GlaxoSmithKline (United Kingdom)","ror":"https://ror.org/01xsqw823","country_code":"GB","type":"company","lineage":["https://openalex.org/I188950975"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Yotaro Numachi","raw_affiliation_strings":["GlaxoSmithKline"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline","institution_ids":["https://openalex.org/I188950975"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.619,"has_fulltext":true,"cited_by_count":5,"citation_normalized_percentile":{"value":0.66924445,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"7","issue":"1","first_page":"55","last_page":"65"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12229","display_name":"Pharmacological Effects and Toxicity Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12267","display_name":"Diet and metabolism studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/lamotrigine","display_name":"lamotrigine","score":0.9919999837875366},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.972000002861023},{"id":"https://openalex.org/keywords/newly-diagnosed-epilepsy","display_name":"newly diagnosed epilepsy","score":0.9890000224113464},{"id":"https://openalex.org/keywords/recurrent-seizures","display_name":"recurrent seizures","score":0.8610000014305115},{"id":"https://openalex.org/keywords/focal-seizures","display_name":"focal seizures","score":0.9190000295639038},{"id":"https://openalex.org/keywords/secondarily-generalized-seizures","display_name":"secondary generalized seizures","score":0.9290000200271606},{"id":"https://openalex.org/keywords/generalized-tonic-clonic-seizures","display_name":"generalized tonic-clonic seizures","score":0.9980000257492065},{"id":"https://openalex.org/keywords/seizure-free-rate","display_name":"seizure-free rate","score":0.9909999966621399},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.875},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6579999923706055},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.7829999923706055}],"concepts":[{"id":"https://openalex.org/C2778802184","wikidata":"https://www.wikidata.org/wiki/Q410346","display_name":"Lamotrigine","level":3,"score":0.9856577515602112},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.786207914352417},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.7584573030471802},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.7580090761184692},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5763279795646667},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.435985267162323},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.4316099286079407},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.42955508828163147},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3289027810096741},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3076910972595215},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.12756553292274475},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.10405516624450684}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3805/eands.7.55","doi":"https://doi.org/10.3805/eands.7.55","is_oa":true,"landing_page_url":"https://doi.org/10.3805/eands.7.55","pdf_url":"https://www.jstage.jst.go.jp/article/eands/7/1/7_55/_pdf","source":{"id":"https://openalex.org/S108509855","display_name":"Epilepsy & Seizure","issn_l":"1882-5567","issn":["1882-5567"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1","poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Epilepsy &amp; Seizure","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.3805/eands.7.55","doi":"https://doi.org/10.3805/eands.7.55","is_oa":true,"landing_page_url":"https://doi.org/10.3805/eands.7.55","pdf_url":"https://www.jstage.jst.go.jp/article/eands/7/1/7_55/_pdf","source":{"id":"https://openalex.org/S108509855","display_name":"Epilepsy & Seizure","issn_l":"1882-5567","issn":["1882-5567"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1","poland-20","russia-white-list-4"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Epilepsy &amp; Seizure","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320324177","display_name":"Otsuka Pharmaceutical","ror":"https://ror.org/013k5y296"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2005297857.pdf","grobid_xml":"https://content.openalex.org/works/W2005297857.grobid-xml"},"referenced_works_count":7,"referenced_works":["https://openalex.org/W2017716131","https://openalex.org/W2027242474","https://openalex.org/W2039674635","https://openalex.org/W2058147010","https://openalex.org/W2095558066","https://openalex.org/W2138521331","https://openalex.org/W2147974822"],"related_works":["https://openalex.org/W2605971581","https://openalex.org/W2381866524","https://openalex.org/W2096416037","https://openalex.org/W2095558066","https://openalex.org/W2113294352","https://openalex.org/W1973888618","https://openalex.org/W2116043268","https://openalex.org/W2075948811","https://openalex.org/W2194920214"],"abstract_inverted_index":{"Purpose:":[0],"To":[1],"evaluate":[2],"the":[3,60,64,96,103,144],"efficacy":[4],"and":[5,25,32,84,95,133,165,172],"safety":[6,176],"of":[7,42,69,79,90,120,178],"lamotrigine":[8,43,141,179,197],"monotherapy":[9,44,142,154,182],"in":[10,30,45,63,102,117,143,159,170,180,189],"patients":[11,46,71,75,86,160,190],"with":[12,27,47,53,140,161,167,191,196],"newly":[13,48,162],"diagnosed":[14,49,163],"partial":[15],"seizures":[16,20,29,169],"including":[17],"secondarily":[18],"generalized":[19,22],"or":[21,51],"tonic-clonic":[23],"seizures,":[24],"those":[26,166],"recurrent":[28,54,168],"Japan":[31,171],"South":[33,173],"Korea.Methods:":[34],"The":[35,56,99,122,137,175],"study":[36,183],"was":[37,59,110,147,184],"a":[38],"multi-center,":[39],"open-label,":[40],"evaluation":[41],"epilepsy":[50,52,164],"seizures.":[55],"primary":[57],"endpoint":[58],"seizure-free":[61,100,138],"rate":[62,101,139],"maintenance":[65,97,104,145],"phase.Results:":[66],"A":[67],"total":[68],"67":[70],"were":[72,115,126],"enrolled;":[73],"52":[74],"completed":[76,87],"6":[77],"weeks":[78,89],"treatment":[80,91],"(the":[81,92],"escalation":[82,93],"phase)":[83],"42":[85],"30":[88],"phase":[94,105,146],"phase).":[98],"for":[106,149],"all":[107,150],"seizure":[108,151],"types":[109],"43.1%.":[111],"Adverse":[112],"events":[113],"(AEs)":[114],"reported":[116],"82%":[118],"(53/65)":[119],"patients.":[121],"most":[123],"common":[124],"AEs":[125],"headache":[127],"(14/65,":[128],"22%),":[129],"nasopharyngitis":[130],"(12/65,":[131],"18%)":[132],"rash":[134],"(7/65,":[135],"11%).Conclusion:":[136],"43.1%":[148],"types.":[152],"Lamotrigine":[153],"appears":[155],"to":[156,186],"be":[157],"effective":[158],"Korea.":[174],"profile":[177],"this":[181],"similar":[185],"that":[187],"observed":[188],"adult":[192],"bipolar":[193],"disorder":[194],"treated":[195],"monotherapy.":[198]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2005297857","counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2}],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}
